Southeast Asia Dose Optimization of Tafenoquine
Southeast Asia Dose Optimization of Tafenoquine
Recruiting · NCT04704999 · Registry updated 2026-10-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Southeast Asia Dose Optimization of Tafenoquine | Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Plasmodium vivax malaria, Recurrence, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 4 | 2026-10-09 | NCT04704999 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Oxford | 213 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Lao Oxford Mahosot Hospital Wellcome Trust Research Unit (LOMWRU) | Vientiane | Laos | 1 |
| Mahidol Oxford Tropical Medicine Research Unit (MORU), Cambodia | Siem Reap | Cambodia | 1 |
| Mahidol Vivax Research Unit (MVRU) | Bangkok | Thailand | 1 |
| Oxford University Clinical Research Unit (OUCRU) | Bình Phước | Vietnam | 2 |
| Oxford University Clinical Research Unit (OUCRU-Indonesia) | Jayapura | Indonesia | 1 |
| Shoklo Malaria Research Unit (SMRU) | Bangkok | Thailand | 1 |